CEO Paul Lang stated that the company achieved $123.5 million of adjusted EBITDA in Q1 2025 despite a soft market environment. Additionally, they returned $106.6 million to shareholders through share ...
The average one-year price target for Core Scientific (NasdaqGS:CORZ) has been revised to $25.48 / share. This is an increase of 18.52% from the prior estimate of $21.49 dated November 7, 2025. The ...
CEO Mark Witkowski highlighted Core & Main's position as a leading North American water infrastructure distributor, noting that "municipal projects represent over 40% of our sales, providing steady, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results